Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information

v3.5.0.2
9. Segment and Geographic Information
6 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

 

    Three Months     Six Months  
    Ended     Ended  
    September 30,     September 30,  
Geographic region   2016     2015     2016     2015  
United States   $ 1,697,000     $ 1,186,000     $ 3,070,000     $ 1,973,000  
Latin America     1,192,000       1,266,000       2,290,000       2,824,000  
Europe and Rest of World     920,000       952,000       1,958,000       1,523,000  
      3,809,000       3,404,000       7,318,000       6,320,000  
Product license fees and royalties     75,000       339,000       150,000       786,000  
Total product related revenues   $ 3,884,000     $ 3,743,000     $ 7,468,000     $ 7,106,000  

 

The following table shows the Company’s product license fees and royalties revenues by partner:

  

    Three Months     Six Months  
    Ended     Ended  
    September 30,     September 30,  
Partner   2016     2015     2016     2015  
Exeltis   $     $ 103,000     $     $ 157,000  
Innovacyn           9,000             29,000  
Laboratorios Sanfer (affiliate of Invekra)     75,000       227,000       150,000       600,000  
Total product license fees and royalties   $ 75,000     $ 339,000     $ 150,000     $ 786,000  

 

The Company’s service revenues amounted to $224,000 and $311,000 for the three months ended September 30, 2016 and 2015, respectively.

 

The Company’s service revenues amounted to $451,000 and $628,000 for the six months ended September 30, 2016 and 2015, respectively.